A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain.
Ciprofloxacin 0.3%/dexamethasone 0.1% (CIP/DEX) and neomycin 0.35%(polymyxin B 10,000 IU/mL/hydrocortisone 1.0% (NPH) were compared for relief of pain in patients with acute otitis externa. Patients received 7 d of treatment with CIP/DEX twice daily or NPH 3 times daily. Ear pain was assessed by patients/caregivers twice daily and by the study investigator on days 3, 8, and 18 (4-point scale). Higher percentages of CIP/DEX-treated patients had relief of severe pain over time (P=.0013) and relief of significant pain (moderate or severe pain) over time (P=.0456), compared with NPH-treated patients. The percentage of CIP/DEXtreated patients with severe pain decreased rapidly within the first 12 h; this contrasted with an increase in pain among NPH-treated patients. CIP/DEX-treated patients had significantly less inflammation (P=.0043) and edema (P=.0148) than NPH-treated patients. Overall, these results support greater pain relief attained over the first 3 d in patients with acute otitis externa treated with CIP/DEX compared with NPH and a rapid reduction in severe pain after initiation of treatment.
Roland
Peter S
PS
Department of Otolaryngology, University of Texas Southwestern Medical School at Dallas, Texas, USA. Peter.Roland@UTSouthwestern.edu
Younis
Ramzi
R
Wall
G Michael
GM
D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000494:pharmacology*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000494:pharmacology; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology; D004359:Drug Therapy, Combination; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000494:pharmacology; D007223:Infant; D009355:Neomycin / Q000008:administration & dosage / Q000494:pharmacology; D010032:Otitis Externa / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D011113:Polymyxins / Q000008:administration & dosage / Q000494:pharmacology; D016037:Single-Blind Method
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D011113:Polymyxins; D002939:Ciprofloxacin; D003907:Dexamethasone; D009355:Neomycin; D006854:Hydrocortisone